Research with a Finnish background facilitates the development of more effective cancer medication
Researchers have identified a gene that drives the development of tumours in over one per cent of all cancer patients. This is the first time that the gene CUX1 has been broadly linked to cancer development.
A Cleveland Clinic-led study shows that a specific type of diabetes drug can decrease the risk of cancer in female patients with type 2 diabetes by up to 32 percent.
Novel discovery relating to the function of RUNX3 gene provides new insights on human defence mechanism against early stages of lung cancer development